Source: Investing.com ↗

Citizens reiterates Intellia stock rating on FDA priority review

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,410.01

+1.37%

ETH/USDT

$2,751.15

+0.95%

ZEC/USDT

$1,624.24

+8.35%

XRP/USDT

$1.63

+6.99%